DPHARMA
Quarterly rpt on consolidated results for the financial period ended 31/12/2002
| DUOPHARMA BIOTECH BHD |
|
Quarterly report for the financial period ended | 31/12/2002 |
| Quarter | 4 |
| Financial Year End | 31/12/2002 |
| The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION31/12/2002 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/12/2002 | 31/12/2001 | 31/12/2002 | 31/12/2001 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
| 1 | Revenue | 15,466 | 0 | 43,126 | 0 |
| 2 | Profit/(loss) before tax | 4,926 | 0 | 12,961 | 0 |
| 3 | Profit/(loss) after tax and minority interest | 3,655 | 0 | 9,565 | 0 |
| 4 | Net profit/(loss) for the period | 3,655 | 0 | 9,565 | 0 |
| 5 | Basic earnings/(loss) per share (sen) | 11.90 | 0.00 | 31.14 | 0.00 |
| 6 | Dividend per share (sen) | 8.00 | 0.00 | 8.00 | 0.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
| 7 | Net tangible assets per share (RM) | 1.5800 | 0.0000 | ||
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
| Remarks : |
| The complete year's results of the Group is reflected in the proforma income statement of the Group as stated in Note A14 |
Announcement Info
| Company Name | DUOPHARMA BIOTECH BHD |
| Stock Name | DBIOTEC |
| Date Announced | 26 Feb 2003 |
| Category | Financial Results |
| Reference No | CU-030224-68152 |